Maja Niedermaier on LinkedIn: Zielgenaue Krebstherapien: Roche-Tochter Foundation Medicine ausgezeichnet…
![Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu](https://www.labiotech.eu/wp-content/uploads/2015/01/Foundation-Medicine-acquired-by-Roche-1200x720.jpg)
Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu
![Foundation Medicine sold for $2.4 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Foundation Medicine sold for $2.4 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research](https://www.stockwinners.com/blog/wp-content/uploads/2018/06/fm-300x146.jpg)
Foundation Medicine sold for $2.4 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research
![Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History](https://cdn.sanity.io/images/ti7si9cx/production/027cc19cfe86f324fb5ec461e5b519bb58a0ea29-1500x750.jpg?w=1382)
Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History
![Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/F1CDx-Kit_Mobi.jpg)
Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews
![Roche's buyout of Foundation Medicine: reaping benefits from Merck's Keytruda - Pharmaceutical Technology Roche's buyout of Foundation Medicine: reaping benefits from Merck's Keytruda - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2018/06/Roches.jpg)
Roche's buyout of Foundation Medicine: reaping benefits from Merck's Keytruda - Pharmaceutical Technology
![West Cancer Center to get more precision treatment options from Foundation Medicine-OneOncology initiative - West Cancer Center West Cancer Center to get more precision treatment options from Foundation Medicine-OneOncology initiative - West Cancer Center](https://westcancercenter.org/wp-content/uploads/2020/08/Foundation-Medicine.jpg)
West Cancer Center to get more precision treatment options from Foundation Medicine-OneOncology initiative - West Cancer Center
![Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy](https://www.dons-gustaveroussy.com/sites/default/files/cppartenariat-fresh-logos-180923.png)
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
![Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy](https://www.gustaveroussy.fr/sites/default/files/cppartenariat-fresh-share-180923.png)
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
![Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu](https://www.labiotech.eu/wp-content/uploads/2015/01/Roche-lab.jpg)